CYTX-- great news! Along with the FDA some time ago greenlighting the Athena trial (the suspension of which caused CYTX to plunge from around $2.10/share down to $0.40s) should mean a return to at least surpass $1.00, more than a double from here....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.